Literature DB >> 1988372

Oncofetal mucin M1 epitope family: characterization and expression during colonic carcinogenesis.

J Bara1, R Gautier, P Mouradian, C Decaens, N Daher.   

Abstract

The gastric mucin M1 antigens, markers associated with colonic carcinogenesis, have been characterized by new antimucin monoclonal antibodies (MAbs). These MAbs, obtained against mucins isolated from a human ovarian mucinous cyst (MAbs 19M1, 21M1 and 45M1) and from a pancreatic adenocarcinoma (MAb 96RA), were compared with 5 other anti-M1 mucin MAbs described previously, which characterized the a, b, c, d and e mucin M1 epitopes. Using immunoperoxidase, these new MAbs exclusively stained the surface gastric epithelium of normal human gastro-intestinal tract and reacted with fetal, precancerous and cancerous colonic mucosa, but not with normal colon. Immunoradiofixation studies showed that these new MAbs are directed against 3 epitopes (f, g and h) which are different from the a, b, c, d and e mucin M1 epitopes, though present on the same a immunoreactive high-molecular-weight components (greater than 1,000 kDa) with a density of 1.4 by CsCl-density-gradient ultracentrifugation. M1 antigenicity is characterized by a family of 8 different M1 epitopes which were destroyed with beta-mercaptoethanol (except for the f epitope), sensitive to a 5 hr trypsin treatment and resistant to 5 mM periodate (except for the h epitope). Some epitopes (b, c and d) showed increasing immunoreactivity after 20 mM periodate treatment, suggesting cryptic location. In rat-colon adenocarcinomas, M1 mucin epitopes were masked but could be decrypted using high periodate treatment, similar to normal rat gastric mucosa, thus suggesting the absence of drastic changes in the saccharide coat of the peptide mucin portion bearing M1 epitopes. Cryptic location, periodate resistance, sensitivity to protease and conformational behavior strongly suggest that the peptidic core of gastric (or fetal colonic) mucin plays a role in M1 immunoreactivity. Indeed, the resurgence of M1 antigens during colonic carcinogenesis is due to re-expression of the peptide core of gastric (or fetal colonic) mucins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988372     DOI: 10.1002/ijc.2910470222

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  AGR2 is induced in asthma and promotes allergen-induced mucin overproduction.

Authors:  Bradley W Schroeder; Catherine Verhaeghe; Sung-Woo Park; Louis T Nguyenvu; Xiaozhu Huang; Guohua Zhen; David J Erle
Journal:  Am J Respir Cell Mol Biol       Date:  2012-03-08       Impact factor: 6.914

2.  Relationship between biological behavior and phenotypic expression in undifferentiated-type gastric carcinomas.

Authors:  Akira Kabashima; Takashi Yao; Yoshihiko Maehara; Masazumi Tsuneyoshi
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

3.  Mucus glycoproteins from pig gastric mucosa: different mucins are produced by the surface epithelium and the glands.

Authors:  H Nordman; J R Davies; I Carlstedt
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

4.  Extremely well-differentiated adenocarcinoma of the stomach: clinicopathological and immunohistochemical features.

Authors:  Takashi Yao; Takashi Utsunomiya; Masafumi Oya; Kenichi Nishiyama; Masazumi Tsuneyoshi
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

5.  Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane cultures.

Authors:  D Meller; R T F Pires; S C G Tseng
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

6.  Heterogeneity in the protein cores of mucins isolated from human middle ear effusions: evidence for expression of different mucin gene products.

Authors:  D A Hutton; F J Fogg; H Kubba; J P Birchall; J P Pearson
Journal:  Glycoconj J       Date:  1998-03       Impact factor: 2.916

7.  Biochemical characterization of a rat oncofetal colonic antigen defined by a monoclonal antibody raised against gastric surface epithelium.

Authors:  C Decaens; J Nardelli; J Bara; P Burtin
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

8.  A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancer.

Authors:  Muhammad S Beg; Nilofer S Azad; Sandip P Patel; Jose Torrealba; Sharon Mavroukakis; Melony A Beatson; Xue Ping Wang; Philip M Arlen; Michael A Morse
Journal:  Cancer Chemother Pharmacol       Date:  2016-07-23       Impact factor: 3.333

9.  Mucin phenotypic expression in early signet ring cell carcinoma of the stomach: its relationship with the clinicopathologic factors.

Authors:  Ryuusuke Aihara; Erito Mochiki; Yoichi Kamiyama; Hitoshi Kamimura; Takayuki Asao; Hiroyuki Kuwano
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

10.  Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil.

Authors:  Yusuke Tajima; Tadakazu Shimoda; Yukihiro Nakanishi; Noboru Yokoyama; Takayuki Tanaka; Kouji Shimizu; Toyohiko Saito; Masatoshi Kawamura; Mitsuo Kusano; Kazuhide Kumagai
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-24       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.